期刊文献+

重组戊型肝炎氢氧化铝佐剂疫苗的磷含量与免疫效力关系研究 被引量:5

Relation between phosphate and immunopotentiation of recombinant HEV-aluminum hydroxide adjuvant vaccines
原文传递
导出
摘要 目的探索氢氧化铝佐剂戊肝疫苗的免疫原性与疫苗中PO_4^(3-)浓度的关系,并分析抗体滴度与抗原在羊淋巴液中吸附率有无相关性。方法用不同浓度PO_4^(3-)处理氢氧化铝佐剂制备试验疫苗,腹腔免疫Balb/c小鼠,ELISA法定量检测免疫后不同时间血清抗体滴度,同时采用钼酸铵还原法检测试验疫苗离心沉淀中的磷含量,根据兰格缪尔方程计算抗原在含不同浓度PO_4^(3-)的佐剂表面的最大吸附量(Γm)。试验疫苗在羊淋巴液中的抗原吸附率采用ELISA法检测。结果随疫苗中PO_4^(3-)浓度增加,抗原最大吸附量(Γm)减小,抗原在羊淋巴液中的吸附率下降,免疫血清抗体滴度渐次增加,直至达到平稳状态。结论在一定范围内增加疫苗磷酸根含量可减小抗原在羊淋巴液中吸附率,降低佐剂对抗原的吸附程度,提高疫苗免疫抗体滴度。 To explore the relationship between phosphate (PO43-) and immunogenicity of HEV-aluminum hydroxide adjuvant vaccine, and to investigate the association of antibody titers with adsorption percentage of antigen in sheep lymph fluid. We prepared experimental vaccines with aluminum-hydroxide adjuvant, which has been pretreated with different quantity of phosphate. The experimental vaccine was used to immunize Balb/c mice intraperitoneally (i.p.). Subsequently, the immune sera at different weeks were collected and the antibody titer was measured quantitatively by ELISA. Phosphorus in precipitate was determined by ammonium molybdate reduction assay after vaccine centrifuge. The adsorptive capacity (Fro) of antigen onto aluminum-hydroxide adjuvant was calculated according to the langmuir adsorption equation. And adsorption percentage of antigen was quantitatively detected by ELISA when experimental vaccines were mixed with sheep lymph fluid. As phosphate in vaccine increased, (Fro) of antigen lowered, and adsorption percentage of antigen decreased after the mix of vaccine with sheep lymph fluid, antibody titer of immune mouse sera raised gradually until steady state. The results suggest that increasing of phosphate content in certain extent of vaccine can decrease adsorption percentage of antigen, reduce antigen adsorption on aluminum adjuvant, but enhance antibody titer.
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第2期120-123,共4页 Immunological Journal
关键词 氢氧化铝佐剂 磷酸根 抗体滴度 吸附率 Aluminum hydroxide adjuvant Phosphate Antibody titer Adsorption percentage
  • 相关文献

参考文献16

  • 1Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention[J]. J Med Virol, 2008, 80 (4): 646-658.
  • 2Li SW, Zhang J, Li YM, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates [J]. Vaccine, 2005, 23 (22): 2893-2901.
  • 3Zhang J, Liu CB, Li RC, et al. Randomized-controlled phase Ⅱ clinical trial of a bacterially expressed recombinant hepatitis E vaccine[J]. Vaccine, 2009, 27 (12): 1869-1874.
  • 4Nail SL, White JL, Hem SL. Structure of aluminum hydroxide gel Ⅰ : initial precipitate [J]. J Pharm Sci, 1976, 65 (8): 1188-1191.
  • 5何萍,吕凤林,陈月,左国伟,李元朝,何凤慈.合成纳米铝佐剂及其对乙型肝炎、狂犬病毒辅佐效应的研究[J].免疫学杂志,2006,22(1):90-93. 被引量:14
  • 6Nail SL, White JL, Hem SL. Structure of aluminum hydroxide gel Ⅱ : aging mechanism [J]. J Pharm Sci, 1976, 65 (8): 1192-1195.
  • 7Chang MF, White JL, Nail SL, et al. Role of the electrostatic attractive force in the adsorption of proteins by aluminum hydroxide adjuvant[J]. PDA J Pharm Sci Tech, 1997, 51 (1): 25-29.
  • 8Rinella JV Jr, White JL, Hem SL. Treatment of aluminium hydroxide adjuvant to optimize the adsorption of basic proteins[J]. Vaccine, 1996, 14 (4): 298-300.
  • 9Levesque PM, Foster K, de Alwis U. Association between immunogenicity and adsorption of a recombinant streptococcus pneumoniae vaccine antigen by an aluminum adjuvant[J]. Human Vaccine, 2006, 2 (2): 74-77.
  • 10al-Shakhshir RH, Regnier FE, White JL, et al. Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-conlaining adjuvant [J]. Vaccine, 1995, 13 (1): 41-44.

二级参考文献11

  • 1He Q,Mitchell AR,Johnson SL,et al.Calcium phosphate nanoparticle adjuvant[J].Clin Diagn Lab Immunol,2000,7(6):899-903.
  • 2Gupta RK,Rost BE,Relyveld E,et al.Adjuvant properties of aluminum and calcium compounds[J].Pharm Biotechnol,1995,6:229-248.
  • 3Duclos P.Safety of immunisation and adverse events following vaccination against hepatitis B[ J ].Expert Opin Drug Saf,2003,2 (3):225-231.
  • 4Bordet AL,Michenet P,Cohen C,et al.Post-vaccination granuloma due to aluminium hydroxide[ J ].Ann Pathol,2001,21 (2):149-152
  • 5Haviv J,Rishpon S,Gdalevich M,et al.Successful postexposure rabies prophylaxis after erroneous starting treatment[J].Prev Med,1999,29 (1):28-31.
  • 6Hanlon CA,Niezgoda M,Morrill PA,et al.The incurable wound revisited:progress in human rabies prevention?[J].Vaccine,2001,19 (17/19):2 273-2 279.
  • 7Raghuvanshi RS,Katare YK,Lalwani K,et al.Improved immune response from biodegradable polymer particles entraiepping tetanus toxoid by use of different immunization protocol and adjuvants[J].Int J Pharm,2002,245(1/2):109-121.
  • 8Tobio M,Sachwendeman SP,Guy Y,et al.Improved immunogenicity of a core coated tetanus toxoid delivery system[J].Vaccine,1999,18 (7/8):618-622.
  • 9Men Y,Audran R,Thomasin C,et al.MHC class Ⅰ and class Ⅱ -restricted processing and presentation of microencapsulated antigens[J].Vaccine,1999,17 (9/10):1 047-1 056
  • 10吕凤林,何凤慈.利用纳米材料制作多肽疫苗佐剂的思考[J].生物化学与生物物理进展,2001,28(6):832-835. 被引量:24

共引文献13

同被引文献94

  • 1寇亚楠,刘石,王瑞宁,耿静微,徐卫松,陈红英,崔保安,杨国宇,魏战勇.纳米铝胶佐剂增强猪细小病毒灭活疫苗猪体免疫的效果[J].中国兽医学报,2015,35(1):25-30. 被引量:6
  • 2王江雪,李玉锋,周国强,李柏,焦芳,陈春英,高愈希,赵宇亮,柴之芳.不同暴露时间TiO_2纳米粒子对雌性小鼠脑单胺类神经递质的影响[J].中华预防医学杂志,2007,41(2):91-95. 被引量:20
  • 3赵爱华,乔来艳,贾淑珍,寇丽杰,王国治.BCG-CpG-DNA对重组HBsAg的免疫佐剂作用[J].中国生物制品学杂志,2007,20(5):356-358. 被引量:16
  • 4Glenny AT, Pope CG, Waddington H, et al. Immunological notes. ⅩⅩⅢ. The antigenic value of toxoid precipitated by potassium alum[J]. J Pathol Baeteriol, 1926, 29: 38-39.
  • 5Brewer JM, Pollock KG. Adjuvant induced Th2- and Th1-dominated immune responses in vaccination[M]//Kaufmann SH. Novel vaccination strategies. Weinheim: Wiley-VCH, 2004:51-72.
  • 6Morefield GL, Jiang D, Romero Mendez IZ, et al. Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid[J]. Vaccine,2005,23 (12): 1502-1506.
  • 7Iyer S, HogenEsch H, Hem SL. Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production [J]. Vaccine,2003, 21 (11/12): 1219-1223.
  • 8Chang M, Shi Y, Nail SL, et al. Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits [J]. Vaccine, 2001, 19 (20/22): 2884-2889.
  • 9al Shakhshir RH, Regnier FE, White JL, et al. Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvant [J]. Vaccine, 1995, 13 (1): 41-44.
  • 10Nail SL, White JL, Hem SL. Structure of aluminum hydroxide gel Ⅰ : initial precipitate [J]. J Pharm Sci, 1976, 65 (8): 1188-1191.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部